MBII - Marrone Bio Innovations, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
0.95
+0.02 (+2.07%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close0.93
Open0.94
Bid0.90 x 800
Ask1.57 x 600
Day's Range0.90 - 0.95
52 Week Range0.85 - 2.45
Volume54,806
Avg. Volume134,534
Market Cap29.783M
Beta-0.13
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Marrone Bio's Amplitude Available for 2018 Growing Season
    Zacks2 days ago

    Marrone Bio's Amplitude Available for 2018 Growing Season

    Marrone Bio's (MBII) unique biofungicide controls soil diseases and white molds on a broad range of large acre crops, pulses, tuber and root crops.

  • Capital Cube15 days ago

    ETFs with exposure to Marrone Bio Innovations, Inc. : November 30, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Marrone Bio Innovations, Inc. Here are 5 ETFs with the largest exposure to MBII-US. Comparing the performance and risk of Marrone Bio Innovations, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Marrone Bio Innovations, Inc. :MBII-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
    Capital Cube17 days ago

    Marrone Bio Innovations, Inc. :MBII-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017

    Categories: Yahoo FinanceGet free summary analysis Marrone Bio Innovations, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Marrone Bio Innovations, Inc. – American Vanguard Corporation, Monsanto Company, Scotts Miracle-Gro Company Class A, FMC Corporation, DowDuPont Inc. and Hawkins, Inc. (AVD-US, MON-US, SMG-US, FMC-US, DWDP-US ... Read more (Read more...)

  • Thomson Reuters StreetEvents23 days ago

    Edited Transcript of MBII earnings conference call or presentation 13-Nov-17 9:30pm GMT

    Q3 2017 Marrone Bio Innovations Inc Earnings Call

  • American City Business Journals24 days ago

    Marrone Bio stock jumps 24 percent as sales increase

    Shares of Davis-based biopesticide company Marrone Bio Innovations Inc. surged to 24 percent on Tuesday, after the company reported a 16.1 percent increase in third-quarter revenue. CEO Pam Marrone, on a conference call with investors and analysts Monday, highlighted several developments that happened in the company's third quarter. Pam Marrone told investors that the company's revenue is typically lowest during the third quarter, and hurricanes that devastated Florida and Puerto Rico reduced sales.

  • Marrone Bio (MBII) Q3 Earnings, Revenues Miss Estimates
    Zackslast month

    Marrone Bio (MBII) Q3 Earnings, Revenues Miss Estimates

    Marrone Bio's (MBII) Q3 loss per share of 27 cents was wider than the Zacks Consensus Estimate of a loss of 24 cents.

  • All You Need To Know About Marrone Bio Innovations Inc’s (MBII) Risks
    Simply Wall St.2 months ago

    All You Need To Know About Marrone Bio Innovations Inc’s (MBII) Risks

    For Marrone Bio Innovations Inc’s (NASDAQ:MBII) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. The betaRead More...

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of MBII earnings conference call or presentation 14-Aug-17 8:30pm GMT

    Q2 2017 Marrone Bio Innovations Inc Earnings Call

  • Marrone Bio's (MBII) Venerate XC Now Available in New York
    Zacks2 months ago

    Marrone Bio's (MBII) Venerate XC Now Available in New York

    Marrone Bio (MBII) has announced the availability of Venerate XC bioinsecticide in New York enabling farmers to manage key pests and reduce chemical residues, while reducing the risk of insecticide resistance.

  • Investopedia3 months ago

    Pot Stock Winners of the Week

    Zynerba had a phenomenal week of trading off positive results from a cannabinoid-based drug trial.

  • Marrone Bio (MBII), Elephant Vert Ink Distribution Deal
    Zacks3 months ago

    Marrone Bio (MBII), Elephant Vert Ink Distribution Deal

    Marrone Bio (MBII) and Elephant Vert landed a distribution agreement in North Africa, which allows the latter to develop two of Marrone Bio's products.

  • Investopedia3 months ago

    Pot Stock Winners of the Week

    Notable gainers this week include Intec Pharma.

  • Capital Cube4 months ago

    ETFs with exposure to Marrone Bio Innovations, Inc. : August 25, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Marrone Bio Innovations, Inc. Here are 5 ETFs with the largest exposure to MBII-US. Comparing the performance and risk of Marrone Bio Innovations, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Marrone Bio Innovations, Inc. :MBII-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017
    Capital Cube4 months ago

    Marrone Bio Innovations, Inc. :MBII-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017

    Categories: Yahoo FinanceGet free summary analysis Marrone Bio Innovations, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Marrone Bio Innovations, Inc. – American Vanguard Corporation, Monsanto Company, Scotts Miracle-Gro Company Class A, FMC Corporation, Syngenta AG Sponsored ADR, Dow Chemical Company and Hawkins, Inc. ... Read more (Read more...)

  • Marrone Bio (MBII) Posts Wider-than-Expected Loss in Q2
    Zacks4 months ago

    Marrone Bio (MBII) Posts Wider-than-Expected Loss in Q2

    Unfavorable weather conditions in key markets affected Marrone Bio (MBII) in Q2.

  • Capital Cube5 months ago

    ETFs with exposure to Marrone Bio Innovations, Inc. : July 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Marrone Bio Innovations, Inc. Here are 5 ETFs with the largest exposure to MBII-US. Comparing the performance and risk of Marrone Bio Innovations, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Marrone Bio Ingredients Gets Nod for Legal Use in California
    Zacks6 months ago

    Marrone Bio Ingredients Gets Nod for Legal Use in California

    Marrone Bio (MBII) announced that three MBI active ingredients can now be legally used on cannabis crops in the Californian market.

  • Capital Cube6 months ago

    ETFs with exposure to Marrone Bio Innovations, Inc. : June 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Marrone Bio Innovations, Inc. Here are 5 ETFs with the largest exposure to MBII-US. Comparing the performance and risk of Marrone Bio Innovations, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Marrone Bio Innovations, Inc. :MBII-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017
    Capital Cube7 months ago

    Marrone Bio Innovations, Inc. :MBII-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017

    Categories: Yahoo FinanceGet free summary analysis Marrone Bio Innovations, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Marrone Bio Innovations, Inc. – American Vanguard Corporation, Monsanto Company, Scotts Miracle-Gro Company Class A, FMC Corporation and Dow Chemical Company (AVD-US, MON-US, SMG-US, FMC-US and DOW-US) ... Read more (Read more...)

  • Marrone Bio's (MBII) Q1 Loss in Line, Revenues Up Y/Y
    Zacks7 months ago

    Marrone Bio's (MBII) Q1 Loss in Line, Revenues Up Y/Y

    Marrone Bio's (MBII) first-quarter loss was in line with the Zacks Consensus Estimate.

  • Capital Cube8 months ago

    ETFs with exposure to Marrone Bio Innovations, Inc. : April 25, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Marrone Bio Innovations, Inc. Here are 5 ETFs with the largest exposure to MBII-US. Comparing the performance and risk of Marrone Bio Innovations, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Capital Cube8 months ago

    ETFs with exposure to Marrone Bio Innovations, Inc. : April 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Marrone Bio Innovations, Inc. Here are 5 ETFs with the largest exposure to MBII-US. Comparing the performance and risk of Marrone Bio Innovations, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Marrone Bio Innovations, Inc. :MBII-US: Earnings Analysis: Q4, 2016 By the Numbers : April 5, 2017
    Capital Cube8 months ago

    Marrone Bio Innovations, Inc. :MBII-US: Earnings Analysis: Q4, 2016 By the Numbers : April 5, 2017

    Categories: Yahoo FinanceGet free summary analysis Marrone Bio Innovations, Inc. reports financial results for the quarter ended December 31, 2016. Highlights Summary numbers: Revenues of USD 2.69 million, Net Earnings of USD -7.81 million. Gross margins widened from -0.58% to 38.96% compared to the same period last year, operating (EBITDA) margins now -204.46% from -434.50%. Change in ... Read more (Read more...)